George L. Bakris
University of Chicago
1007 Papers
5.2K Citations
George L. Bakris is an academic researcher from University of Chicago. The author has contributed to research in topics: Medicine & Kidney disease. The author has an hindex of 119, co-authored 881 publications. Previous affiliations of George L. Bakris include Rush University Medical Center & Bristol-Myers Squibb.
Chat about Author
Papers
Potential Role and Limitations of Estimated Glomerular Filtration Rate Slope Assessment in Cardiovascular Trials: A Review.
TL;DR: In this paper , the estimated glomerular filtration rate (eGFR) slope has demonstrated strong association with subsequent progression to end-stage kidney disease (ESKD) outcomes.
19
Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial
Arya M. Sharma,George L. Bakris,Joel M. Neutel,Thomas W. Littlejohn,Maureen Kobe,Naitee Ting,Ludwin Ley +6 more
TL;DR: In this selected population of patients with diabetes and hypertension, T/A provided prompt and greater BP decreases compared with A monotherapy, with the majority of patients achieving the BP goal.
19
Diabetic hypertensive patients: improving their prognosis.
TL;DR: Retrospective analyses demonstrate that a reduction in blood pressure, especially to levels of <130/85 mg Hg in diabetic patients, retards the progression of renal disease.
18
The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.
George L. Bakris,David S.H. Bell,Vivian Fonseca,Richard E. Katholi,Janet B. McGill,Robert A. Phillips,Philip Raskin,Jackson T. Wright,Malini Iyengar,Terry Holeslaw,Karen M. Anderson +10 more
TL;DR: The GEMINI trial is the first large randomized trial to assess whether utilizing a third-generation beta-blocker yields a favorable metabolic profile in the patient with Type 2 diabetes and hypertension.
18
Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndrome.
Xavier Rossello,Xavier Rossello,João Pedro Ferreira,Francisca Caimari,Zohra Lamiral,Abhinav Sharma,Cyrus R. Mehta,George L. Bakris,Christopher P. Cannon,William B. White,Faiez Zannad +10 more
TL;DR: In this article, the influence of race, age and gender on major adverse cardiovascular events (MACE) and on heart failure events was assessed in a large post-ACS trial (EXAMINE).
18